Kinnate Biopharma Inc. to Participate in the 2022 Piper Sandler Heartland Summit
SAN FRANCISCO and SAN DIEGO, Sept. 15, 2022 (GLOBE NEWSWIRE) -- Kinnate Biopharma Inc .
- SAN FRANCISCO and SAN DIEGO, Sept. 15, 2022 (GLOBE NEWSWIRE) -- Kinnate Biopharma Inc .
- (Nasdaq: KNTE) (Kinnate), a clinical-stage precision oncology company, today announced that its chief executive officer, Nima Farzan , will participate in the Piper Sandler Heartland Summit as part of the panel Healthcare Politics: FDA Proposals from Optimus, to ORBIS to RTOR and CONFIRM How Might These Proposals Impact Oncology Drug Development and Implications?
- Kinnate Biopharma Inc. is a clinical-stage precision oncology company focused on expanding on the promise of targeted therapies for those battling cancer.
- Words such as believes, anticipates, plans, expects, intends, will, goal, potential and similar expressions are also intended to identify forward-looking statements.